nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—CYP1A2—Methimazole—Graves' disease	0.143	0.426	CbGbCtD
Pazopanib—CYP2D6—Methimazole—Graves' disease	0.118	0.351	CbGbCtD
Pazopanib—CYP3A4—Methimazole—Graves' disease	0.075	0.223	CbGbCtD
Pazopanib—Ageusia—Methimazole—Graves' disease	0.0103	0.0801	CcSEcCtD
Pazopanib—Skin ulcer—Propylthiouracil—Graves' disease	0.00909	0.0709	CcSEcCtD
Pazopanib—Ageusia—Propylthiouracil—Graves' disease	0.00873	0.0681	CcSEcCtD
Pazopanib—TAOK1—eye—Graves' disease	0.00794	0.023	CbGeAlD
Pazopanib—SH2B3—eye—Graves' disease	0.00747	0.0216	CbGeAlD
Pazopanib—MAP3K9—thyroid gland—Graves' disease	0.00677	0.0196	CbGeAlD
Pazopanib—ITK—adipose tissue—Graves' disease	0.00645	0.0186	CbGeAlD
Pazopanib—LYN—connective tissue—Graves' disease	0.00606	0.0175	CbGeAlD
Pazopanib—FGFR3—connective tissue—Graves' disease	0.00603	0.0174	CbGeAlD
Pazopanib—TAOK1—pituitary gland—Graves' disease	0.00589	0.017	CbGeAlD
Pazopanib—TAOK1—adipose tissue—Graves' disease	0.00587	0.017	CbGeAlD
Pazopanib—Hepatic failure—Propylthiouracil—Graves' disease	0.00571	0.0446	CcSEcCtD
Pazopanib—ITK—thyroid gland—Graves' disease	0.00558	0.0161	CbGeAlD
Pazopanib—SH2B3—pituitary gland—Graves' disease	0.00555	0.016	CbGeAlD
Pazopanib—SH2B3—adipose tissue—Graves' disease	0.00553	0.016	CbGeAlD
Pazopanib—TAOK1—thyroid gland—Graves' disease	0.00508	0.0147	CbGeAlD
Pazopanib—FLT4—eye—Graves' disease	0.00488	0.0141	CbGeAlD
Pazopanib—SH2B3—thyroid gland—Graves' disease	0.00478	0.0138	CbGeAlD
Pazopanib—STK16—pituitary gland—Graves' disease	0.00472	0.0136	CbGeAlD
Pazopanib—AURKC—thyroid gland—Graves' disease	0.00471	0.0136	CbGeAlD
Pazopanib—STK16—adipose tissue—Graves' disease	0.0047	0.0136	CbGeAlD
Pazopanib—RIOK2—pituitary gland—Graves' disease	0.00464	0.0134	CbGeAlD
Pazopanib—RIOK2—adipose tissue—Graves' disease	0.00463	0.0134	CbGeAlD
Pazopanib—BMPR1B—adipose tissue—Graves' disease	0.00458	0.0132	CbGeAlD
Pazopanib—Jaundice—Methimazole—Graves' disease	0.00454	0.0354	CcSEcCtD
Pazopanib—MAP3K2—connective tissue—Graves' disease	0.00444	0.0128	CbGeAlD
Pazopanib—FGF1—eye—Graves' disease	0.00434	0.0125	CbGeAlD
Pazopanib—FGF1—connective tissue—Graves' disease	0.00418	0.0121	CbGeAlD
Pazopanib—STK36—pituitary gland—Graves' disease	0.00417	0.0121	CbGeAlD
Pazopanib—STK36—adipose tissue—Graves' disease	0.00415	0.012	CbGeAlD
Pazopanib—PI4KB—pituitary gland—Graves' disease	0.00411	0.0119	CbGeAlD
Pazopanib—FGFR2—eye—Graves' disease	0.0041	0.0118	CbGeAlD
Pazopanib—PI4KB—adipose tissue—Graves' disease	0.00409	0.0118	CbGeAlD
Pazopanib—STK16—thyroid gland—Graves' disease	0.00407	0.0118	CbGeAlD
Pazopanib—LIMK2—pituitary gland—Graves' disease	0.00403	0.0117	CbGeAlD
Pazopanib—LIMK2—adipose tissue—Graves' disease	0.00402	0.0116	CbGeAlD
Pazopanib—RIOK2—thyroid gland—Graves' disease	0.004	0.0116	CbGeAlD
Pazopanib—BMPR1B—thyroid gland—Graves' disease	0.00396	0.0115	CbGeAlD
Pazopanib—FGFR2—connective tissue—Graves' disease	0.00395	0.0114	CbGeAlD
Pazopanib—Jaundice—Propylthiouracil—Graves' disease	0.00386	0.0301	CcSEcCtD
Pazopanib—FLT1—eye—Graves' disease	0.0038	0.011	CbGeAlD
Pazopanib—Alopecia—Methimazole—Graves' disease	0.00369	0.0288	CcSEcCtD
Pazopanib—FLT1—connective tissue—Graves' disease	0.00366	0.0106	CbGeAlD
Pazopanib—FLT4—adipose tissue—Graves' disease	0.00361	0.0104	CbGeAlD
Pazopanib—PIP4K2C—pituitary gland—Graves' disease	0.0036	0.0104	CbGeAlD
Pazopanib—STK36—thyroid gland—Graves' disease	0.0036	0.0104	CbGeAlD
Pazopanib—PIP4K2C—adipose tissue—Graves' disease	0.00359	0.0104	CbGeAlD
Pazopanib—TAOK3—eye—Graves' disease	0.00358	0.0103	CbGeAlD
Pazopanib—FGFR1—pituitary gland—Graves' disease	0.00358	0.0103	CbGeAlD
Pazopanib—Haemoglobin—Propylthiouracil—Graves' disease	0.00357	0.0279	CcSEcCtD
Pazopanib—FGFR1—adipose tissue—Graves' disease	0.00356	0.0103	CbGeAlD
Pazopanib—Haemorrhage—Propylthiouracil—Graves' disease	0.00355	0.0277	CcSEcCtD
Pazopanib—PI4KB—thyroid gland—Graves' disease	0.00354	0.0102	CbGeAlD
Pazopanib—LIMK2—thyroid gland—Graves' disease	0.00348	0.0101	CbGeAlD
Pazopanib—TAOK3—connective tissue—Graves' disease	0.00345	0.00997	CbGeAlD
Pazopanib—PDGFRA—connective tissue—Graves' disease	0.00343	0.00991	CbGeAlD
Pazopanib—MAP3K2—adipose tissue—Graves' disease	0.0034	0.00984	CbGeAlD
Pazopanib—Leukopenia—Methimazole—Graves' disease	0.00326	0.0254	CcSEcCtD
Pazopanib—FGF1—pituitary gland—Graves' disease	0.00322	0.00931	CbGeAlD
Pazopanib—KDR—eye—Graves' disease	0.00321	0.00928	CbGeAlD
Pazopanib—FGF1—adipose tissue—Graves' disease	0.00321	0.00927	CbGeAlD
Pazopanib—LCK—adipose tissue—Graves' disease	0.00319	0.00921	CbGeAlD
Pazopanib—Alopecia—Propylthiouracil—Graves' disease	0.00314	0.0245	CcSEcCtD
Pazopanib—CSF1R—eye—Graves' disease	0.00313	0.00905	CbGeAlD
Pazopanib—FLT4—thyroid gland—Graves' disease	0.00312	0.00903	CbGeAlD
Pazopanib—PIP4K2C—thyroid gland—Graves' disease	0.00311	0.00898	CbGeAlD
Pazopanib—Arthralgia—Methimazole—Graves' disease	0.0031	0.0242	CcSEcCtD
Pazopanib—Myalgia—Methimazole—Graves' disease	0.0031	0.0242	CcSEcCtD
Pazopanib—KDR—connective tissue—Graves' disease	0.00309	0.00894	CbGeAlD
Pazopanib—FGFR1—thyroid gland—Graves' disease	0.00308	0.00891	CbGeAlD
Pazopanib—Dysgeusia—Propylthiouracil—Graves' disease	0.00303	0.0236	CcSEcCtD
Pazopanib—FGFR2—adipose tissue—Graves' disease	0.00303	0.00875	CbGeAlD
Pazopanib—CSF1R—connective tissue—Graves' disease	0.00302	0.00872	CbGeAlD
Pazopanib—Oedema—Methimazole—Graves' disease	0.00297	0.0232	CcSEcCtD
Pazopanib—MAP3K2—thyroid gland—Graves' disease	0.00295	0.00851	CbGeAlD
Pazopanib—Thrombocytopenia—Methimazole—Graves' disease	0.00291	0.0227	CcSEcCtD
Pazopanib—FLT1—pituitary gland—Graves' disease	0.00282	0.00815	CbGeAlD
Pazopanib—FLT1—adipose tissue—Graves' disease	0.00281	0.00811	CbGeAlD
Pazopanib—EPHB6—pituitary gland—Graves' disease	0.00279	0.00805	CbGeAlD
Pazopanib—PDGFRB—eye—Graves' disease	0.00278	0.00803	CbGeAlD
Pazopanib—FGF1—thyroid gland—Graves' disease	0.00278	0.00802	CbGeAlD
Pazopanib—EPHB6—adipose tissue—Graves' disease	0.00277	0.00802	CbGeAlD
Pazopanib—Leukopenia—Propylthiouracil—Graves' disease	0.00277	0.0216	CcSEcCtD
Pazopanib—LCK—thyroid gland—Graves' disease	0.00276	0.00797	CbGeAlD
Pazopanib—KIT—connective tissue—Graves' disease	0.00274	0.00792	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Methimazole—Graves' disease	0.0027	0.0211	CcSEcCtD
Pazopanib—PDGFRB—connective tissue—Graves' disease	0.00268	0.00774	CbGeAlD
Pazopanib—Paraesthesia—Methimazole—Graves' disease	0.00267	0.0208	CcSEcCtD
Pazopanib—TAOK3—pituitary gland—Graves' disease	0.00266	0.00768	CbGeAlD
Pazopanib—STK10—adipose tissue—Graves' disease	0.00266	0.00768	CbGeAlD
Pazopanib—TAOK3—adipose tissue—Graves' disease	0.00265	0.00765	CbGeAlD
Pazopanib—Somnolence—Methimazole—Graves' disease	0.00264	0.0206	CcSEcCtD
Pazopanib—Myalgia—Propylthiouracil—Graves' disease	0.00263	0.0205	CcSEcCtD
Pazopanib—Arthralgia—Propylthiouracil—Graves' disease	0.00263	0.0205	CcSEcCtD
Pazopanib—PDGFRA—adipose tissue—Graves' disease	0.00263	0.0076	CbGeAlD
Pazopanib—FGFR2—thyroid gland—Graves' disease	0.00262	0.00758	CbGeAlD
Pazopanib—Dyspepsia—Methimazole—Graves' disease	0.00261	0.0204	CcSEcCtD
Pazopanib—Oedema—Propylthiouracil—Graves' disease	0.00252	0.0197	CcSEcCtD
Pazopanib—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00247	0.0193	CcSEcCtD
Pazopanib—FLT1—thyroid gland—Graves' disease	0.00243	0.00702	CbGeAlD
Pazopanib—EPHB6—thyroid gland—Graves' disease	0.0024	0.00694	CbGeAlD
Pazopanib—KDR—pituitary gland—Graves' disease	0.00238	0.00689	CbGeAlD
Pazopanib—MAP2K5—pituitary gland—Graves' disease	0.00238	0.00689	CbGeAlD
Pazopanib—KDR—adipose tissue—Graves' disease	0.00237	0.00686	CbGeAlD
Pazopanib—MAP2K5—adipose tissue—Graves' disease	0.00237	0.00686	CbGeAlD
Pazopanib—CSF1R—pituitary gland—Graves' disease	0.00232	0.00672	CbGeAlD
Pazopanib—CSF1R—adipose tissue—Graves' disease	0.00232	0.00669	CbGeAlD
Pazopanib—STK10—thyroid gland—Graves' disease	0.0023	0.00665	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.0023	0.0179	CcSEcCtD
Pazopanib—TAOK3—thyroid gland—Graves' disease	0.00229	0.00662	CbGeAlD
Pazopanib—PDGFRA—thyroid gland—Graves' disease	0.00228	0.00658	CbGeAlD
Pazopanib—Paraesthesia—Propylthiouracil—Graves' disease	0.00227	0.0177	CcSEcCtD
Pazopanib—Somnolence—Propylthiouracil—Graves' disease	0.00224	0.0175	CcSEcCtD
Pazopanib—Dyspepsia—Propylthiouracil—Graves' disease	0.00222	0.0173	CcSEcCtD
Pazopanib—KIT—pituitary gland—Graves' disease	0.00211	0.0061	CbGeAlD
Pazopanib—KIT—adipose tissue—Graves' disease	0.0021	0.00608	CbGeAlD
Pazopanib—Pruritus—Methimazole—Graves' disease	0.0021	0.0164	CcSEcCtD
Pazopanib—PDGFRB—pituitary gland—Graves' disease	0.00206	0.00596	CbGeAlD
Pazopanib—KDR—thyroid gland—Graves' disease	0.00205	0.00594	CbGeAlD
Pazopanib—MAP2K5—thyroid gland—Graves' disease	0.00205	0.00594	CbGeAlD
Pazopanib—PDGFRB—adipose tissue—Graves' disease	0.00205	0.00594	CbGeAlD
Pazopanib—CSF1R—thyroid gland—Graves' disease	0.002	0.00579	CbGeAlD
Pazopanib—Vomiting—Methimazole—Graves' disease	0.00189	0.0147	CcSEcCtD
Pazopanib—Rash—Methimazole—Graves' disease	0.00187	0.0146	CcSEcCtD
Pazopanib—Dermatitis—Methimazole—Graves' disease	0.00187	0.0146	CcSEcCtD
Pazopanib—Headache—Methimazole—Graves' disease	0.00186	0.0145	CcSEcCtD
Pazopanib—KIT—thyroid gland—Graves' disease	0.00182	0.00526	CbGeAlD
Pazopanib—Pruritus—Propylthiouracil—Graves' disease	0.00179	0.0139	CcSEcCtD
Pazopanib—PDGFRB—thyroid gland—Graves' disease	0.00178	0.00514	CbGeAlD
Pazopanib—Nausea—Methimazole—Graves' disease	0.00176	0.0138	CcSEcCtD
Pazopanib—Vomiting—Propylthiouracil—Graves' disease	0.0016	0.0125	CcSEcCtD
Pazopanib—Rash—Propylthiouracil—Graves' disease	0.00159	0.0124	CcSEcCtD
Pazopanib—Dermatitis—Propylthiouracil—Graves' disease	0.00159	0.0124	CcSEcCtD
Pazopanib—Headache—Propylthiouracil—Graves' disease	0.00158	0.0123	CcSEcCtD
Pazopanib—Nausea—Propylthiouracil—Graves' disease	0.0015	0.0117	CcSEcCtD
Pazopanib—CYP2C8—pituitary gland—Graves' disease	0.00119	0.00345	CbGeAlD
Pazopanib—ABCG2—pituitary gland—Graves' disease	0.00116	0.00335	CbGeAlD
Pazopanib—ABCG2—adipose tissue—Graves' disease	0.00115	0.00334	CbGeAlD
Pazopanib—ABCG2—thyroid gland—Graves' disease	0.000999	0.00289	CbGeAlD
Pazopanib—CYP1A2—thyroid gland—Graves' disease	0.000961	0.00278	CbGeAlD
Pazopanib—ABCB1—pituitary gland—Graves' disease	0.000571	0.00165	CbGeAlD
Pazopanib—ABCB1—adipose tissue—Graves' disease	0.000569	0.00165	CbGeAlD
Pazopanib—ABCB1—thyroid gland—Graves' disease	0.000493	0.00142	CbGeAlD
Pazopanib—FLT4—Signaling Pathways—IL2RA—Graves' disease	0.000123	0.000645	CbGpPWpGaD
Pazopanib—PDGFRB—MAPK Signaling Pathway—TNF—Graves' disease	0.000122	0.000644	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000122	0.000642	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—HLA-B—Graves' disease	0.000122	0.000641	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—HLA-B—Graves' disease	0.000121	0.00064	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—HLA-A—Graves' disease	0.000121	0.000637	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GC—Graves' disease	0.000121	0.000635	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD40—Graves' disease	0.00012	0.000634	CbGpPWpGaD
Pazopanib—LCK—HIV Infection—CD4—Graves' disease	0.00012	0.000631	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CD8A—Graves' disease	0.00012	0.000631	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—CXCL10—Graves' disease	0.00012	0.00063	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000119	0.000628	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—HLA-A—Graves' disease	0.000119	0.000626	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CTLA4—Graves' disease	0.000119	0.000625	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IFIH1—Graves' disease	0.000118	0.000623	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—CD4—Graves' disease	0.000118	0.000622	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TSHR—Graves' disease	0.000117	0.000619	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000117	0.000615	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—IL2RA—Graves' disease	0.000116	0.000612	CbGpPWpGaD
Pazopanib—LYN—Immune System—IFIH1—Graves' disease	0.000116	0.00061	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000116	0.000609	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000116	0.000609	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—HLA-B—Graves' disease	0.000115	0.000607	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—HLA-B—Graves' disease	0.000114	0.0006	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD8A—Graves' disease	0.000114	0.000599	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—CD4—Graves' disease	0.000113	0.000597	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000113	0.000597	CbGpPWpGaD
Pazopanib—ITK—Immune System—IL1B—Graves' disease	0.000113	0.000597	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—HLA-A—Graves' disease	0.000113	0.000594	CbGpPWpGaD
Pazopanib—LCK—Disease—B3GNT2—Graves' disease	0.000113	0.000593	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—HLA-A—Graves' disease	0.000113	0.000593	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—HLA-B—Graves' disease	0.000112	0.000588	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD8A—Graves' disease	0.000111	0.000586	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—HLA-E—Graves' disease	0.000111	0.000586	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000111	0.000582	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.00011	0.000578	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—HLA-B—Graves' disease	0.000109	0.000576	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000109	0.000576	CbGpPWpGaD
Pazopanib—KIT—Immune System—HLA-E—Graves' disease	0.000109	0.000575	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD40—Graves' disease	0.000109	0.000572	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000109	0.000572	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL2RA—Graves' disease	0.000108	0.000569	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—B3GNT2—Graves' disease	0.000108	0.000567	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—HLA-B—Graves' disease	0.000107	0.000564	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CTLA4—Graves' disease	0.000107	0.000564	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—HLA-A—Graves' disease	0.000107	0.000562	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD40—Graves' disease	0.000107	0.000562	CbGpPWpGaD
Pazopanib—FGF1—Immune System—HLA-DQB1—Graves' disease	0.000107	0.000561	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—ICAM1—Graves' disease	0.000106	0.000559	CbGpPWpGaD
Pazopanib—KIT—Immune System—CTLA4—Graves' disease	0.000105	0.000554	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—ICAM1—Graves' disease	0.000104	0.000549	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HLA-E—Graves' disease	0.000104	0.000546	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HLA-E—Graves' disease	0.000103	0.000544	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000103	0.000543	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000103	0.000541	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—HLA-A—Graves' disease	0.000101	0.000534	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD40—Graves' disease	0.000101	0.000534	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD40—Graves' disease	0.000101	0.000532	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000101	0.000531	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CTLA4—Graves' disease	9.99e-05	0.000526	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CTLA4—Graves' disease	9.96e-05	0.000524	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD8A—Graves' disease	9.95e-05	0.000524	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—HLA-A—Graves' disease	9.93e-05	0.000523	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—ICAM1—Graves' disease	9.89e-05	0.000521	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—ICAM1—Graves' disease	9.87e-05	0.00052	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—B3GNT2—Graves' disease	9.87e-05	0.00052	CbGpPWpGaD
Pazopanib—FGFR3—Disease—HLA-A—Graves' disease	9.86e-05	0.000519	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—CD4—Graves' disease	9.82e-05	0.000517	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—HLA-DQB1—Graves' disease	9.78e-05	0.000515	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—HLA-DRB1—Graves' disease	9.75e-05	0.000514	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TSHR—Graves' disease	9.72e-05	0.000512	CbGpPWpGaD
Pazopanib—FGF1—Immune System—HLA-B—Graves' disease	9.58e-05	0.000504	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TSHR—Graves' disease	9.55e-05	0.000503	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—IL2RA—Graves' disease	9.52e-05	0.000501	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFIH1—Graves' disease	9.5e-05	0.0005	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—CD4—Graves' disease	9.43e-05	0.000496	CbGpPWpGaD
Pazopanib—ABCB1—Allograft Rejection—TNF—Graves' disease	9.41e-05	0.000495	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—ICAM1—Graves' disease	9.36e-05	0.000493	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HLA-E—Graves' disease	9.31e-05	0.000491	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—HLA-DRB1—Graves' disease	9.26e-05	0.000488	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—HLA-B—Graves' disease	9.15e-05	0.000482	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL2RA—Graves' disease	9.14e-05	0.000481	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—B3GNT2—Graves' disease	9.14e-05	0.000481	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CXCL10—Graves' disease	9.13e-05	0.000481	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD8A—Graves' disease	9.13e-05	0.000481	CbGpPWpGaD
Pazopanib—LYN—Immune System—HLA-E—Graves' disease	9.12e-05	0.00048	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD40—Graves' disease	9.1e-05	0.000479	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—HLA-DRB1—Graves' disease	9.07e-05	0.000478	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TSHR—Graves' disease	9.06e-05	0.000477	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TSHR—Graves' disease	9.04e-05	0.000476	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—IL1B—Graves' disease	8.99e-05	0.000474	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CTLA4—Graves' disease	8.97e-05	0.000473	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL2RA—Graves' disease	8.97e-05	0.000473	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD40—Graves' disease	8.91e-05	0.000469	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—ICAM1—Graves' disease	8.89e-05	0.000468	CbGpPWpGaD
Pazopanib—FGF1—Immune System—HLA-A—Graves' disease	8.87e-05	0.000467	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—HLA-DQB1—Graves' disease	8.82e-05	0.000465	CbGpPWpGaD
Pazopanib—LYN—Immune System—CTLA4—Graves' disease	8.79e-05	0.000463	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—HLA-B—Graves' disease	8.78e-05	0.000462	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—ICAM1—Graves' disease	8.7e-05	0.000458	CbGpPWpGaD
Pazopanib—KIT—Immune System—HLA-DQB1—Graves' disease	8.66e-05	0.000456	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD8A—Graves' disease	8.24e-05	0.000434	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HLA-DQB1—Graves' disease	8.22e-05	0.000433	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HLA-DQB1—Graves' disease	8.2e-05	0.000432	CbGpPWpGaD
Pazopanib—FGF1—Disease—HLA-A—Graves' disease	8.19e-05	0.000431	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CXCL10—Graves' disease	8.16e-05	0.00043	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TSHR—Graves' disease	8.14e-05	0.000429	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—HLA-A—Graves' disease	8.14e-05	0.000428	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—CD4—Graves' disease	8.12e-05	0.000428	CbGpPWpGaD
Pazopanib—FGF1—Immune System—HLA-DRB1—Graves' disease	8.11e-05	0.000427	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD8A—Graves' disease	8.09e-05	0.000426	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—CD4—Graves' disease	7.98e-05	0.00042	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TSHR—Graves' disease	7.97e-05	0.00042	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CXCL10—Graves' disease	7.96e-05	0.000419	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—HLA-B—Graves' disease	7.92e-05	0.000417	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—TNF—Graves' disease	7.81e-05	0.000411	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—CD4—Graves' disease	7.8e-05	0.000411	CbGpPWpGaD
Pazopanib—KIT—Immune System—HLA-B—Graves' disease	7.78e-05	0.00041	CbGpPWpGaD
Pazopanib—FGF1—Immune System—ICAM1—Graves' disease	7.78e-05	0.00041	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD8A—Graves' disease	7.68e-05	0.000404	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—CD4—Graves' disease	7.66e-05	0.000403	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD8A—Graves' disease	7.66e-05	0.000403	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CXCL10—Graves' disease	7.59e-05	0.0004	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—CD4—Graves' disease	7.57e-05	0.000399	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—CD4—Graves' disease	7.55e-05	0.000398	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GC—Graves' disease	7.48e-05	0.000394	CbGpPWpGaD
Pazopanib—LCK—Immune System—HLA-E—Graves' disease	7.48e-05	0.000394	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—HLA-DRB1—Graves' disease	7.43e-05	0.000391	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL2RA—Graves' disease	7.43e-05	0.000391	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HLA-DQB1—Graves' disease	7.39e-05	0.000389	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HLA-B—Graves' disease	7.39e-05	0.000389	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HLA-B—Graves' disease	7.37e-05	0.000388	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—HLA-A—Graves' disease	7.34e-05	0.000387	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD40—Graves' disease	7.31e-05	0.000385	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL2RA—Graves' disease	7.29e-05	0.000384	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—CD4—Graves' disease	7.27e-05	0.000383	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—CD4—Graves' disease	7.25e-05	0.000382	CbGpPWpGaD
Pazopanib—LYN—Immune System—HLA-DQB1—Graves' disease	7.23e-05	0.000381	CbGpPWpGaD
Pazopanib—KIT—Immune System—HLA-A—Graves' disease	7.21e-05	0.00038	CbGpPWpGaD
Pazopanib—LCK—Immune System—CTLA4—Graves' disease	7.2e-05	0.000379	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—ICAM1—Graves' disease	7.13e-05	0.000376	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IFNG—Graves' disease	7.12e-05	0.000375	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL2RA—Graves' disease	6.98e-05	0.000368	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL2RA—Graves' disease	6.92e-05	0.000364	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL2RA—Graves' disease	6.9e-05	0.000364	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD8A—Graves' disease	6.9e-05	0.000363	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CD4—Graves' disease	6.88e-05	0.000362	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HLA-A—Graves' disease	6.84e-05	0.00036	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HLA-A—Graves' disease	6.83e-05	0.000359	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—CD4—Graves' disease	6.8e-05	0.000358	CbGpPWpGaD
Pazopanib—FGFR2—Disease—HLA-A—Graves' disease	6.78e-05	0.000357	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD8A—Graves' disease	6.76e-05	0.000356	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—HLA-DRB1—Graves' disease	6.71e-05	0.000353	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—CD4—Graves' disease	6.66e-05	0.000351	CbGpPWpGaD
Pazopanib—KIT—Disease—HLA-A—Graves' disease	6.66e-05	0.000351	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HLA-B—Graves' disease	6.64e-05	0.00035	CbGpPWpGaD
Pazopanib—KIT—Immune System—HLA-DRB1—Graves' disease	6.59e-05	0.000347	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TSHR—Graves' disease	6.53e-05	0.000344	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD4—Graves' disease	6.53e-05	0.000344	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GC—Graves' disease	6.52e-05	0.000343	CbGpPWpGaD
Pazopanib—LYN—Immune System—HLA-B—Graves' disease	6.5e-05	0.000342	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—ICAM1—Graves' disease	6.44e-05	0.000339	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD4—Graves' disease	6.4e-05	0.000337	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL1B—Graves' disease	6.35e-05	0.000335	CbGpPWpGaD
Pazopanib—FGFR3—Disease—CD4—Graves' disease	6.35e-05	0.000334	CbGpPWpGaD
Pazopanib—KIT—Immune System—ICAM1—Graves' disease	6.32e-05	0.000333	CbGpPWpGaD
Pazopanib—FGFR1—Disease—HLA-A—Graves' disease	6.32e-05	0.000333	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—HLA-A—Graves' disease	6.3e-05	0.000332	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CXCL10—Graves' disease	6.28e-05	0.000331	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HLA-DRB1—Graves' disease	6.25e-05	0.000329	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL2RA—Graves' disease	6.24e-05	0.000329	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HLA-DRB1—Graves' disease	6.24e-05	0.000328	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL2RA—Graves' disease	6.22e-05	0.000328	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CXCL10—Graves' disease	6.17e-05	0.000325	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HLA-A—Graves' disease	6.15e-05	0.000324	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GC—Graves' disease	6.14e-05	0.000323	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL2RA—Graves' disease	6.09e-05	0.000321	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL2RA—Graves' disease	6.08e-05	0.00032	CbGpPWpGaD
Pazopanib—LYN—Immune System—HLA-A—Graves' disease	6.02e-05	0.000317	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—ICAM1—Graves' disease	6e-05	0.000316	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—ICAM1—Graves' disease	5.99e-05	0.000315	CbGpPWpGaD
Pazopanib—LCK—Immune System—HLA-DQB1—Graves' disease	5.93e-05	0.000312	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IFNG—Graves' disease	5.92e-05	0.000312	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CXCL10—Graves' disease	5.85e-05	0.000308	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CXCL10—Graves' disease	5.84e-05	0.000308	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2RA—Graves' disease	5.8e-05	0.000305	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—TNF—Graves' disease	5.75e-05	0.000303	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD4—Graves' disease	5.72e-05	0.000301	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—HLA-A—Graves' disease	5.68e-05	0.000299	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—B3GNT2—Graves' disease	5.67e-05	0.000299	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HLA-DRB1—Graves' disease	5.62e-05	0.000296	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD8A—Graves' disease	5.54e-05	0.000292	CbGpPWpGaD
Pazopanib—LYN—Immune System—HLA-DRB1—Graves' disease	5.5e-05	0.00029	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—CD4—Graves' disease	5.46e-05	0.000288	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—ICAM1—Graves' disease	5.39e-05	0.000284	CbGpPWpGaD
Pazopanib—LCK—Immune System—HLA-B—Graves' disease	5.33e-05	0.00028	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL1B—Graves' disease	5.28e-05	0.000278	CbGpPWpGaD
Pazopanib—LYN—Immune System—ICAM1—Graves' disease	5.28e-05	0.000278	CbGpPWpGaD
Pazopanib—FGF1—Disease—CD4—Graves' disease	5.28e-05	0.000278	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCL10—Graves' disease	5.26e-05	0.000277	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD4—Graves' disease	5.24e-05	0.000276	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GC—Graves' disease	5.2e-05	0.000274	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCL10—Graves' disease	5.15e-05	0.000271	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—TNF—Graves' disease	5.05e-05	0.000266	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2RA—Graves' disease	4.99e-05	0.000263	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—B3GNT2—Graves' disease	4.94e-05	0.00026	CbGpPWpGaD
Pazopanib—LCK—Immune System—HLA-A—Graves' disease	4.94e-05	0.00026	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IFNG—Graves' disease	4.9e-05	0.000258	CbGpPWpGaD
Pazopanib—KIT—Immune System—IFNG—Graves' disease	4.81e-05	0.000253	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2RA—Graves' disease	4.8e-05	0.000253	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD4—Graves' disease	4.73e-05	0.000249	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2RA—Graves' disease	4.72e-05	0.000248	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—B3GNT2—Graves' disease	4.65e-05	0.000245	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD4—Graves' disease	4.65e-05	0.000245	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	4.64e-05	0.000244	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IFNG—Graves' disease	4.57e-05	0.00024	CbGpPWpGaD
Pazopanib—LCK—Disease—HLA-A—Graves' disease	4.56e-05	0.00024	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IFNG—Graves' disease	4.55e-05	0.00024	CbGpPWpGaD
Pazopanib—LCK—Immune System—HLA-DRB1—Graves' disease	4.51e-05	0.000237	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2RA—Graves' disease	4.47e-05	0.000236	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2RA—Graves' disease	4.46e-05	0.000235	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD4—Graves' disease	4.41e-05	0.000232	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD4—Graves' disease	4.4e-05	0.000232	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL1B—Graves' disease	4.37e-05	0.00023	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CD4—Graves' disease	4.37e-05	0.00023	CbGpPWpGaD
Pazopanib—LCK—Immune System—ICAM1—Graves' disease	4.33e-05	0.000228	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL1B—Graves' disease	4.29e-05	0.000226	CbGpPWpGaD
Pazopanib—KIT—Disease—CD4—Graves' disease	4.29e-05	0.000226	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL10—Graves' disease	4.22e-05	0.000222	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IFNG—Graves' disease	4.1e-05	0.000216	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL1B—Graves' disease	4.07e-05	0.000214	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CD4—Graves' disease	4.07e-05	0.000214	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL1B—Graves' disease	4.06e-05	0.000214	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CD4—Graves' disease	4.06e-05	0.000214	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2RA—Graves' disease	4.02e-05	0.000212	CbGpPWpGaD
Pazopanib—LYN—Immune System—IFNG—Graves' disease	4.02e-05	0.000212	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GC—Graves' disease	4.02e-05	0.000211	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD4—Graves' disease	3.96e-05	0.000209	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—B3GNT2—Graves' disease	3.94e-05	0.000208	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2RA—Graves' disease	3.94e-05	0.000207	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD4—Graves' disease	3.88e-05	0.000204	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL1B—Graves' disease	3.66e-05	0.000193	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD4—Graves' disease	3.66e-05	0.000193	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL1B—Graves' disease	3.58e-05	0.000189	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFNG—Graves' disease	3.29e-05	0.000173	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2RA—Graves' disease	3.23e-05	0.00017	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD4—Graves' disease	3.18e-05	0.000167	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—B3GNT2—Graves' disease	3.04e-05	0.00016	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—Graves' disease	2.94e-05	0.000155	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—Graves' disease	2.94e-05	0.000155	CbGpPWpGaD
